Add BrightSurf on Google Email

New review maps advances in coronary intravascular imaging and computational methods to support safer, personalized percutaneous coronary intervention for heart disease patients

Recent technical and computational improvements in coronary intravascular imaging can better characterize coronary lesions and identify high-risk plaques, improving outcomes for patients with coronary artery disease. The review highlights advances in imaging platforms, hybrid imaging systems, and artificial-intelligence approaches for ...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeLiterature review·DateSep 27, 2026

Air pollution and cardiovascular disease: mitochondria may be the missing link

Researchers have discovered novel blood biomarkers, long-chain dicarboxylate acids (DCAs) and medium- to long-chain acyl-carnitines (ACs), in mouse and human blood samples exposed to air pollution. These biomarkers provide insights into how air pollution damages cell function and increases the risk of heart disease. The buildup of thes...

SourceUniversity of California - Los Angeles Health Sciences·JournalArteriosclerosis Thrombosis and Vascular Biology·TypeData/statistical analysis·DateSep 24, 2026

Weight loss alone does not explain lower heart disease for those on semaglutide

A new study suggests that semaglutide reduces heart disease risk beyond just weight loss, but the exact mechanism is unclear. The study analyzed data from a clinical trial of semaglutide, which found that patients taking the drug had a 20% lower risk of heart disease, but only half of this reduction could be explained by changes in kno...

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeRandomized controlled/clinical trial·DateSep 23, 2026

Efficacy and safety of semaglutide according to frailty status

A recent study found semaglutide to be effective in improving various clinical outcomes in patients with frailty, with greater benefits observed in those with higher frailty indices. The medication demonstrated a positive impact on health-related quality of life, highlighting its potential as a treatment option for this population.

SourceJAMA Network·JournalJAMA Cardiology·DateSep 16, 2026

Family Heart Foundation study demonstrates how the FIND Lp(a) machine learning model enables targeted Lp(a) screening

The study demonstrates the FIND Lp(a) model's ability to identify individuals with high Lp(a) more than twice as likely as the overall population with ASCVD. The model supports targeted Lp(a) screening, accelerating universal screening adoption and enhancing cardiovascular risk management.

SourceFamily Heart Foundation·JournalJACC Advances·TypeData/statistical analysis·DateSep 14, 2026

Joint Statement from the American College of Cardiology, The Society of Thoracic Surgeons, and the Society for Cardiovascular Angiography & Interventions on transcatheter aortic valve replacement national coverage determination

The American College of Cardiology, Society of Thoracic Surgeons, and Society for Cardiovascular Angiography & Interventions released a joint statement on TAVR national coverage determination. The statement aims to preserve the quality framework that contributed to TAVR's success, emphasizing the importance of collaborations, registrie...

Scoring system could help doctors identify patients at high risk of intramyocardial hemorrhage and guide treatment and monitoring

A new scoring system developed by researchers at Upstate Medical University can help identify patients at high risk of intramyocardial hemorrhage after a heart attack, guiding treatment and monitoring. The system uses explainable artificial intelligence to predict patient risk in real-time, allowing doctors to make informed decisions.

SourceState University of New York Upstate Medical University·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateSep 10, 2026

Strength training not linked to heart problems for people with arrhythmogenic cardiomyopathy

Researchers found no association between strength training and increased risks of ventricular arrhythmia for people with arrhythmogenic cardiomyopathy. A retrospective review of 355 participants showed that endurance exercise was associated with a higher risk of ventricular arrhythmia compared to strength training.

SourceJohns Hopkins Medicine·JournalJACC Clinical Electrophysiology·TypeObservational study·DateSep 10, 2026

Even low levels of nighttime light exposure may weaken the heart, increase the risk of cardiovascular disease

Even low levels of nighttime light exposure can lead to structural changes in the heart, increasing the risk of cardiovascular disease. Researchers analyzed data from 11,017 participants and found that those exposed to higher levels of light saw a thickening of the heart's walls and reduced flexibility during a heartbeat.

SourceTulane University·JournalEuropean Heart Journal·TypeObservational study·DateSep 9, 2026

Why some stroke patients fare better than others

A new study from the University of Colorado Boulder reveals how the brain's defense mechanism can backfire, forming micro-clots that damage tissue after the original clot is gone. This phenomenon, known as no reflow, affects up to 50% of stroke patients and can lead to long-term disability or death.

SourceUniversity of Colorado at Boulder·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 2, 2026

Japanese scientists develop heart-in-a-dish model of heart relaxation failure

Researchers have developed a human engineered heart tissue model of diastolic heart failure, enabling treatment testing with SGLT2 inhibitors, which partially prevented disease development. The model demonstrated anti-inflammatory effects of SGLT2i, improving ion exchanger function and preventing accumulation of ions in tissues.

SourceFujita Health University·JournalCell Stem Cell·TypeExperimental study·DateSep 2, 2026

NYU Langone Health names Sunil Rao, MD, Director of the Leon H. Charney Division of Cardiology and welcomes Susheel Kodali, MD, to lead interventional cardiology

NYU Langone Health has appointed Sunil Rao, MD, and Susheel Kodali, MD, as directors of the Leon H. Charney Division of Cardiology and interventional cardiology, respectively. Dr. Rao will oversee a nationally ranked cardiology program, while Dr. Kodali will lead the Cardiac Catheterization Laboratory and expand treatment options for p...

Eminent cardiologist involved in treatment guidelines received £50m from drug research contracts

A British cardiologist and former president of the European Society of Cardiology has been found to have committed severe misconduct after receiving over £50m from lucrative drug research contracts. The investigation found that Kim Fox and his wife had served as co-directors of a contract research organisation involved in running clini...

SourceBMJ Group·JournalThe BMJ·TypeNews article·DateAug 26, 2026

Meta analysis finds 87% 12 month freedom from atrial fibrillation with artificial intelligence enhanced catheter ablation for persistent atrial fibrillation

A systematic review and meta-analysis published in Cardiology Discovery shows AI-guided spatiotemporal dispersion area ablation yields an 87% pooled 12-month freedom-from-atrial-fibrillation rate for patients living with persistent atrial fibrillation. The technique aims to standardize substrate identification while preserving patient-...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeLiterature review·DateAug 25, 2026

Single arm study finds dapagliflozin linked to 19% relative improvement in left ventricular ejection fraction among non diabetic Egyptian heart failure patients

A single-arm observational study found dapagliflozin improves left ventricular ejection fraction by 19% in non-diabetic Egyptian heart failure patients. The study demonstrated significant echocardiographic improvements and a low rate of mild short-term adverse events.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeObservational study·DateAug 24, 2026

New clinical framework shifts coronary disease care away from vessel narrowing toward atherosclerotic plaque centered early intervention

A new clinical framework reorients coronary disease management toward early detection and stabilization of atherosclerotic plaques. The framework proposes a risk-stratified screening pathway for adults aged 40 or older with at least one traditional cardiac risk factor.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeCommentary/editorial·DateAug 20, 2026

Perspective highlights real-world “risk-treatment-paradox”: highest-risk non-ST-elevation heart-attack patients often do not receive guideline-recommended early invasive care

A narrative perspective calls for multidimensional patient assessment beyond risk scores to address care disparities in non-ST-elevation myocardial infarction. Younger patients with ongoing ischemia may benefit from early angiography despite moderate risk scores.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeCommentary/editorial·DateAug 20, 2026

Review outlines practical strategies to cut residual cardiovascular events for acute coronary syndrome survivors

A new review in Cardiology Discovery provides a structured clinical framework to identify and manage residual cardiovascular risks for patients surviving acute coronary syndrome. The framework groups risks into four categories and summarizes therapeutic options, emphasizing personalized risk re-evaluation for individual patients.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeLiterature review·DateAug 20, 2026

Review maps expanding treatment options for hypertrophic cardiomyopathy, an inherited leading cause of sudden cardiac death in young adults

A comprehensive review highlights recent progress and emerging therapies for hypertrophic cardiomyopathy, including cardiac myosin inhibitors, interventional techniques, and gene-based approaches. The treatment options now offer expanded pathways for both obstructive and non-obstructive patient subgroups, but limitations and uncertaint...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeLiterature review·DateAug 20, 2026

Cold and room-temperature platelets in cardiac surgery

Researchers found that cold storage platelets (CSPs) can control active surgical bleeding as effectively as room temperature platelets (RTPs), with potential benefits including reduced wastage and increased platelet availability. CSPs may also enable platelet incorporation into inventory at locations with limited shelf life for RTPs.

SourceJAMA Network·JournalJAMA·DateAug 17, 2026

Doctors may now see the hidden signs of sudden cardiac death

Columbia researchers have developed a new technique to capture electrical activity and mechanical motion within the heart using cardiac ultrasound images. This technology allows for early detection and risk assessment of Mitral Valve Disease and arrhythmias, transforming care for those suffering from these conditions.

SourceColumbia University School of Engineering and Applied Science·JournalProceedings of the National Academy of Sciences·DateAug 17, 2026

Central hub for heart repair discovered

Scientists at University Hospital of Bonn identified a signaling pathway in the immune system that helps newborn heart cells survive and regenerate after injury. The discovery opens new possibilities for therapies aimed at repairing damaged adult hearts, which have limited regenerative capacity compared to neonatal hearts.

SourceUniversitatsklinikum Bonn·JournalCell Communication and Signaling·DateAug 17, 2026

Blood-thinning medication linked to slower cognitive decline

A study from Karolinska Institutet found that people treated with modern NOAC blood-thinning medicines experienced a slower rate of cognitive decline compared to those receiving warfarin or no anticoagulant treatment. This was associated with lower risk of other health problems, including death, stroke, and fractures.

SourceKarolinska Institutet·JournalEuropean Heart Journal·TypeObservational study·DateAug 12, 2026

Unexpected findings add new insight on cannabis and heart health

Researchers discovered a statistically significant reduction in premature atrial contractions after cannabis inhalation, with no impact on daily activity levels. The findings challenge assumptions about the cardiovascular effects of cannabis and may lead to new approaches for preventing or treating abnormal heart rhythms.

SourceUniversity of California - San Francisco·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateAug 12, 2026

Cardiovascular care for older adults should account for cognitive impairment and frailty

A new ACC Scientific Statement highlights the importance of considering cognitive impairment and frailty in cardiovascular care for older adults. The statement outlines practical strategies for prevention, screening, assessment, and management, aiming to improve outcomes such as independence, mobility, and caregiver burden.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateAug 10, 2026

Physical fitness and all-cause mortality in older adults

Objective physical fitness assessments reveal a graded association between balance, agility, strength, and cardiorespiratory fitness with reduced all-cause mortality. This study suggests integrating fitness assessments into routine practice may improve risk stratification and guide function-oriented interventions.

SourceJAMA Network·JournalJAMA Network Open·DateAug 10, 2026

ALARA+ Coalition launches toolkits to speed adoption of enhanced radiation protection in cath labs

The ALARA+ Coalition has released a suite of resources to help hospital leadership and decisionmakers implement enhanced radiation and occupational safety guidelines for clinicians and staff working in fluoroscopy laboratories. The new toolkits provide practical steps to protect cath lab team members from both occupational radiation ex...

Hemodialysis mortality risks by blood type

A large-scale prospective cohort study found that patients with blood type A had lower risks of all-cause and cardiovascular mortality. In contrast, blood type O's reputation of being at lower risk is partially due to lower plasma von Willebrand factor levels, but this did not explain the increased risk in blood type A patients.

SourceOsaka Metropolitan University·JournalKidney International Reports·TypeObservational study·DateJul 21, 2026